Back to catalogue
№ 008 20 filings · 2021-05-18 → 2026-02-17

ABERDEEN EQUITY INCOME TRUST PLC

AEI
Financial Services Market cap £336m Overall fit 120 /1000

Poor fit for the strategy: a UK value/income investment trust with negligible AI exposure (1.9% tech weight), no operating leverage at the corporate level (fees scale with NAV), and — taking the supplied £326.1m mcap at face value — trading at roughly twice the trust's own published NAV. Even ignoring the apparent data anomaly, this is a defensive income vehicle, not a long-tail AI play.

Fair value range 315p–345p Mid case · £157m
Absolute upside -53.3% vs current market cap
Conviction 4/5 confidence in overvalued call
Supports the call
  • NAV is a Level-1 hard anchor
  • Clean 24-year disclosure history
  • Closed-end structure with quoted holdings only
Limits the call
  • Given £326.1m market cap cannot be reconciled with trust's own share count and reported share price — likely a data error
  • Discount/premium can drift 0-10% with sentiment
Methodology

Published NAV per share with normal discount/premium range

In one line · bull case

High and growing 7.1% dividend yield from a cheap, index-agnostic UK value portfolio trading close to NAV, with a 24-year unbroken dividend track record.

In one line · biggest risk

Manager's index-agnostic mid/small-cap value tilt has lagged the FTSE All-Share materially over 3 and 5 years; continued underperformance would re-widen the discount and undermine NAV TR.

Drivers
AI beneficiary 8 /100
Portfolio is UK value/income — tobacco, banks, oil, utilities, miners; tech weight only 1.9%.
Operating leverage 10 /100
Investment trust — management fee scales with NAV, so no fixed-cost dilution benefit from rising AUM.
Earnings vs expectations 55 /100
Has reliably met or marginally beaten its own dividend guidance for 24 years; NAV total returns have lagged the index.
Growth momentum 40 /100
NAV broadly flat over the period; dividend grows ~0.4% p.a.; H1 FY25 NAV TR +2.1%.
Moat 20 /100
No structural moat; differentiation is manager skill and the closed-end income wrapper.
Earnings quality 85 /100
Level-1 quoted holdings, transparent NAV, clean audit history, low ongoing charges of 0.84%.
Management quality 60 /100
Thomas Moore in post since 2011; consistent process and dividend record, though 3- and 5-year NAV returns have lagged.
Cyclicality 55 /100
Tracks UK equity market with 13.9% gearing — moderately cyclical via underlying holdings.
Leverage 30 /100
Net gearing 13.9% via £22.5m revolving credit facility at SONIA + spread (6.04% all-in).
Value-trap signals · 3
  • 3- and 5-year NAV TR materially lags FTSE All-Share
  • Persistent risk of discount re-widening if mid/small-cap tilt remains out of favour
  • Regulatory overhang from FCA Consumer Composite Investments regime and sector activism

Aberdeen Equity Income Trust plc (AEI) — Research Note

Executive summary

Aberdeen Equity Income Trust is a UK closed-end investment trust (not an operating company) holding ~55 quoted UK equities with an index-agnostic, "Focus on Change" value/income tilt managed by Thomas Moore since 2011. Across the 5-year period the NAV has been volatile (FY20 -25.7%, FY21 +39.9%, FY22 -7.6%, FY23 +1.8%, FY24 +13.3%, H1 FY25 +2.1%), the dividend has been grown to a 24-year unbroken track record (23.0p indicated for FY25, ~7.1% yield), and the discount has narrowed from ~12.5% in 2020 to essentially flat (0.5% at 31 March 2025). The single most important point for valuation today is that AEI is a closed-end fund whose fair value is, almost by definition, its underlying NAV — at the latest published market cap of £326.1m the shares are trading roughly at a premium to the trust's most recently disclosed NAV per share.

Fair value estimate

Methodology: NAV-based fair value range. For closed-end investment trusts the natural fair value anchor is the published cum-income NAV per share, adjusted for the typical trading range of the discount/premium.

  • Latest disclosed NAV/share: 327.01p at 31 March 2025 2025-05 H1.
  • Net assets £156.2m on 47,781,522 shares in issue (1,397,245 treasury) 2025-05 H1.
  • Implied market cap if shares trade at NAV: ~£156m.
  • The "latest disclosed market cap" of £326.1m given by the question, divided by the same 47.78m shares, implies a share price of ~683p, more than 2x the most recent NAV of 327p. This is incompatible with the trust's own disclosures (share price 325.5p at 31 March 2025; NAV essentially flat thereafter at a small premium).

Fair value range per share: 315p – 345p (NAV per share ± a normal 0–5% discount/premium range that this trust has actually traded in over the past 18 months).

Implied market cap range: £150m – £165m.

Comparison to "current" market cap (£326.1m): this figure appears anomalous — either an erroneous data point or based on something other than 47.78m ordinary shares outstanding. Against the trust's own disclosed NAV the shares would need to be at ~683p to support a £326m cap, vs. the actually reported 325.5p at the last reporting date. Treating the £326.1m figure at face value gives an apparent ~50% downside; treating the most-recently-reported share price (~325.5p) as the relevant anchor implies the shares are roughly fair.

Conviction caveat: I'd flag the £326.1m figure to the user as likely a data error before acting on it.

Sector context

  • Sector classification per question: Financials / Financial Services — correct in ICB terms; mechanically AEI is a closed-end UK equity investment trust.
  • Quality/growth/leverage profile: in line with peers. Net gearing 13.9% (within 5%–15% policy band) is typical of UK equity-income trusts; ongoing charges 0.84% are low-to-average for the sector; 7.1% yield is at the high end of UK equity income trusts.
  • Listed peers: Edinburgh Investment Trust (EDIN), Murray Income Trust (MUT), City of London Investment Trust (CTY), Lowland (LWI), Dunedin Income Growth (DIG).

Investment thesis (3 bullets)

  • Reliable, growing, well-covered dividend with a 24-year track record now extending to 25 — the FY25 plan is 23.0p (+0.4%), supported by H1 revenue earnings +12.4% YoY to 10.17p 2025-05 H1. At a 7.1% yield it is among the highest of any UK equity income trust.
  • Discount has collapsed and stayed tight — from ~10% in March 2024 to 0.5% at March 2025, with shares trading at a small premium post-period 2025-05 H1. The trust's value/income tilt is back in favour as the "US exceptionalism" narrative cracks and capital rotates to UK and European value 2025-05 H1.
  • Underlying portfolio is genuinely cheap on absolute and relative measures — median P/E of 8.6x and P/Book 1.2x vs. 11.6x and 1.5x for FTSE All-Share ex-IT 2025-05 H1, with bid activity (DS Smith, Centamin, Industrials REIT in earlier periods) periodically crystallising value.

Key risks (3 bullets)

  • Active-management/process risk: 3- and 5-year NAV total returns of 6.1% and 61.2% have lagged FTSE All-Share at 23.3% and 76.5% 2025-05 H1. The index-agnostic mid/small-cap tilt has hurt during large-cap leadership phases.
  • Gearing amplifies drawdowns: 13.9% net gearing at a 6.04% SONIA-based borrowing cost 2025-05 H1; in a down market the £22.5m RBSI facility magnifies NAV losses.
  • Sector concentration: 40% Financials, 15% Energy, 9.6% Consumer Staples (notably tobacco at >9% across Imperial Brands + BAT) 2025-05 H1 — narrow income base, exposed to dividend cuts in any one of these sectors (e.g. Diversified Energy cut 2024, Vanquis profit warning 2024).

Operating leverage

Operating leverage is essentially not applicable in the traditional sense — AEI is an externally-managed investment trust, not an operating business. Its cost base is dominated by a fixed-rate 0.55% management fee on net assets plus ~£0.45m of administrative expenses, giving a total ongoing charges ratio of 0.84% 2025-05 H1. Because fees scale with NAV rather than being fixed, there is no "fixed cost dilution" benefit if markets rise — the cost ratio is largely constant. The only operating leverage of note is financial leverage: the £22.5m drawn facility means a 10% market move in the underlying portfolio translates roughly 1:1.14 into NAV (gearing of ~14%). There is no business model here that converts a revenue surprise into a multiple of profit; the trust simply tracks the underlying portfolio.

Value-trap signals

None identified at the trust level — closed-end NAV is a hard anchor, dividend is covered with reserves, ongoing charges are low and stable. The relevant "trap" risk is at the portfolio level: continued underperformance vs. the index could re-widen the discount, especially given (a) Consumer Composite Investments regulatory regime risk flagged by the board 2025-05 H1 and (b) heightened activist shareholder activity in the IT sector that has already pressured several sub-scale trusts.

Earnings vs. expectations

Trusts do not provide "earnings guidance" or have analyst consensus in the corporate sense. The relevant metric is dividend delivery vs. board guidance:

  • FY22 board guided "at least 21.8p"; delivered 22.7p. Beat.
  • FY23 board guided "at least 22.8p"; delivered 22.8p. Met.
  • FY24 board guided "at least 22.9p"; delivered 22.9p (5.70p × 3 + 5.80p). Met.
  • FY25 board guidance: at least 23.0p, on track per H1 2025-05 H1.

The trust has reliably met or marginally beaten its own dividend guidance and has hit its NAV objective of revenue cover since FY22. Portfolio NAV has consistently lagged the FTSE All-Share over 3 and 5 years; income delivery has consistently met expectations.

Conviction

Conviction: 4 (high) that the fair value of this trust is essentially its NAV per share (315p–345p range allowing for normal discount fluctuation), implying ~£150–165m market cap.

  • Anchors: NAV is published, Level 1 quoted holdings, audited; minimal valuation ambiguity; 24-year financial history with clean accounting and no related-party issues.
  • Limits: I cannot reconcile the question's "£326.1m latest disclosed market cap" with the trust's own filings (latest reported share price 325.5p × 47.78m shares ≈ £155m). If the £326.1m is correct it implies either a share split, a major new issue, or a data error I cannot explain from the filings. Also: future NAV depends on UK equity market performance and the manager's value/income tilt being rewarded.

Driver scoring summary

This trust is not an AI beneficiary in any meaningful sense. The portfolio is UK income/value — tobacco, banks, oil, utilities, miners, life insurers, housebuilders. Tech weight is 1.9% 2025-05 H1. Operating leverage at the corporate level is essentially nil — fees scale with NAV. Long-tail AI upside for this fund is structurally negligible: it cannot benefit asymmetrically from an AI capex super-cycle in the way the investor wants. For an "AI-receiver + operating leverage + valuation discipline" portfolio this is a low-fit holding regardless of intrinsic quality.

Flag to user: The supplied "latest disclosed market cap" of £326.1m cannot be reconciled with the trust's own filings (47,781,522 shares × ~325.5p share price = ~£155m at the last reporting date, with NAV per share of 327.01p). I have scored the stock as overvalued at the supplied £326.1m figure, but if that number is a data error the correct view at the trust's actually-reported share price is fair value, view = fair, with absolute_upside_pct close to zero.

Filings consulted · 22

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-02-17Result OF Agm2026-02-17_9434827_result-of-agm.md0.30
  2. 2025-12-17Doc RE Annual Report2025-12-17_9301608_doc-re-annual-report.md0.95
  3. 2025-05-27Doc RE Half Yearly Report2025-05-27_8898320_doc-re-half-yearly-report.md0.58
  4. 2025-05-15Half Year Report2025-05-15_8878835_half-year-report.md0.58
  5. 2025-02-18Result OF Agm2025-02-18_8742022_result-of-agm.md0.20
  6. 2024-06-13Half Yearly Report2024-06-13_8258235_half-yearly-report.md0.58
  7. 2024-05-14Half Year Report2024-05-14_8193861_half-year-report.md0.41
  8. 2024-02-20Result OF Agm2024-02-20_8047115_result-of-agm.md0.14
  9. 2023-12-19Doc RE Annual Report2023-12-19_7951912_doc-re-annual-report.md0.43
  10. 2023-05-26Doc RE Half Yearly Report2023-05-26_7547155_doc-re-half-yearly-report.md0.23
  11. 2023-05-16Half Year Report2023-05-16_7528085_half-year-report.md0.23
  12. 2023-02-02Result OF Agm2023-02-02_7354155_result-of-agm.md0.07
  13. 2022-11-28Company Secretary Change OF Name2022-11-28_7216717_company-secretary-change-of-name.md0.15
  14. 2022-08-01Alternative Investment Fund Manager Change OF Name2022-08-01_6956137_alternative-investment-fund-manager-change-of-name.md0.15
  15. 2022-05-27Doc RE Half Yearly Report2022-05-27_7030763_doc-re-half-yearly-report.md0.23
  16. 2022-05-19Half Year Report2022-05-19_6932977_half-year-report.md0.23
  17. 2022-04-06Change OF Name2022-04-06_6863919_change-of-name.md0.15
  18. 2022-02-04Result OF Agm2022-02-04_6746678_result-of-agm.md0.07
  19. 2022-02-04Dividend Declaration2022-02-04_6746688_dividend-declaration.md0.07
  20. 2021-12-23Doc RE Annual Report2021-12-23_6605568_doc-re-annual-report.md0.24
  21. 2021-05-26Doc RE Half Yearly Report2021-05-26_6515307_doc-re-half-yearly-report.md0.09
  22. 2021-05-18Half Year Report2021-05-18_6431437_half-year-report.md0.09

This research note was authored by a large language model after reading 20 regulatory filings published between 2021-05-18 and 2026-02-17. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.